The Effect of an Electronic Decision Support System on Preventing Pressure Ulcers and Urinary Infectionsin Home Care

NCT ID: NCT06927479

Last Updated: 2025-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-01

Study Completion Date

2026-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The home care of fully dependent patients is often provided by informal family caregivers. Therefore, caregivers need support systems to make the right decisions during home care to prevent pressure ulcers and urinary infections. This study aims to evaluate the impact of using an electronic decision support system (E-DSS), offered through a mobile-compatible webpage, on preventing the risk of pressure ulcers and urinary infections in fully dependent patients receiving home healthcare services.

The study is planned in two phases. In the first phase, the development of the electronic decision support system to be provided through a mobile-compatible webpage is targeted. In the second phase, a randomized controlled trial will be conducted to assess the usability of the developed decision support system by caregivers.

For the project, patients with a Barthel Index score between 0-20 (if an insufficient number of patients is available, those scoring between 21-61 will also be included) will be selected and divided into intervention and control groups. Caregivers of the intervention group will use the electronic decision support system via a mobile-compatible webpage for eight weeks to receive guidance on preventing pressure ulcers, urinary infection prevention strategies, in-bed mobilization, and nutrition recommendations. Caregivers in the control group will continue with the routine practices of the home healthcare services provided by the Turkish Ministry of Health.

The study outcomes will be evaluated at the beginning and at the ninth week using the Braden Pressure Ulcer Risk Scale, the Ghent Global IAD Classification Tool (GLOBIAD), the ISTAP Skin Tear Classification System, urinalysis (UA), the Urine Color Scale, and the Mini Nutritional Assessment-Short Form (MNA-SF). Additionally, at the end of the study, caregivers in the intervention group will be assessed using the System Usability Scale (SUS-TR), the Mobile Application Usability Scale, the Mobile Application Loyalty Scale, and the Mobile Application Willingness to Use Scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Support of the Family as a Caregiving System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A Randomized Controlled Study
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Caregivers in this group will use the electronic decision support system (E-DSS) provided via a mobile-compatible web page. E-DSS will be used to optimize the daily care management of patients and to reduce the risk of pressure ulcers and the risks that predict this risk, such as nutrition and hydration, position changes and in-bed activities. E-DSS will analyze the data obtained from the participants and provide personalized recommendations. Caregivers in the intervention group will receive this training over a period of two weeks, with ongoing support and reinforcement provided throughout the eight-week intervention period via the Electronic Decision Support System (E-DSS).

Group Type EXPERIMENTAL

Training about Electronic Decision Support System

Intervention Type OTHER

1. System Registration and Usage
2. Pressure Ulcer Prevention
3. Urinary Infection Prevention
4. Nutrition and Hydration Management
5. Physical Activity and In-Bed Mobilization
6. Emergency Management and Reporting
7. Continuous Monitoring and Feedback

Control group

This group will contiue with home care services by Health Ministriy ot Turkiye

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Training about Electronic Decision Support System

1. System Registration and Usage
2. Pressure Ulcer Prevention
3. Urinary Infection Prevention
4. Nutrition and Hydration Management
5. Physical Activity and In-Bed Mobilization
6. Emergency Management and Reporting
7. Continuous Monitoring and Feedback

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients receiving home healthcare services.
2. Patients with a total Barthel Index score of 0-20 (fully dependent) and 21-61 (severely dependent).
3. Caregivers who are familiar with using mobile devices and voluntarily agree to participate.

Exclusion Criteria

1. Patients with a Barthel Index score of 62 or above.
2. Patients with an acute medical condition (e.g., hospitalization due to infection or newly developed severe illness).
3. Caregivers with cognitive or technological limitations preventing
4. Caregivers who are not literate in Turkish and unable to use the application.
5. Terminal-stage patients\* with a life expectancy of a short period.
6. Caregivers with severe cognitive impairment (e.g., advanced-stage dementia) or untreated psychiatric disorders (e.g., schizophrenia).
7. Patients without an informal caregiver providing care at home.
8. Patients with an existing urinary infection based on hospital urinalysis records.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Akdeniz University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sebahat Gozum

Prof.Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sebahat Gözüm, Prof.Dr.

Role: CONTACT

+9002423106916

Yusuf Güver, PhDc

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TBAEK-257

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.